US2020024298A1PendingUtilityA1
Process for the preparation of fluticasone propionate form i
Est. expiryJul 8, 2031(~4.9 yrs left)· nominal 20-yr term from priority
A61P 29/00A61P 11/02A61P 17/06A61P 17/00C07B 2200/13A61K 9/0075C07J 31/006Y10T428/2982C07J 31/00A61P 11/00
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a novel crystallisation process for preparing fluticasone propionate as crystalline form 1 polymorph with controlled particle size and suitable for micronisation. Said process comprises the step of dissolving fluticasone propionate in acetone or in a mixture of acetone and water and then adding this solution to water or to a mixture of water 10 and acetone, thereby causing fluticasone propionate to crystallise out of the solution as crystalline form.
Claims
exact text as granted — not AI-modified1 . A process for preparing fluticasone propionate as crystalline polymorphic form 1, the process comprising: dissolving fluticasone propionate in a solvent to form a solution, and then adding the solution to a non-solvent, thereby causing fluticasone propionate to crystallise out of the solution as crystalline form 1;
wherein the solvent comprises acetone and from 0% to 10% water, based on the volume of the solvent; and wherein the non-solvent comprises water and from 0% to 35% acetone, based on the volume of the non-solvent.
2 . A process according to claim 1 , wherein fluticasone propionate is dissolved in the solvent in an amount between 30 and 50 grams per litre of solvent.
3 . A process according to claim 1 , wherein fluticasone propionate is dissolved in a first defined volume of the solvent to form a solution, and the solution is then added to a second defined volume of the non-solvent;
a ratio of the first defined volume to the second defined volume being between 1:0.65 and 1:1.35.
4 . A process according to claim 2 , wherein fluticasone propionate is dissolved in a first defined volume of the solvent to form a solution, and the solution is then added to a second defined volume of the non-solvent;
a ratio of the first defined volume to the second defined volume being between 1:0.65 and 1:1.35.
5 . A process according to claim 1 , wherein said adding the solution takes place at a temperature between about 10° C. and about 40° C.
6 . A process according to claim 1 , wherein said adding the solution takes place over a period of between about 10 minutes and about 6 hours.
7 . A process according to claim 5 , wherein said adding the solution takes place over a period of between about 10 minutes and about 6 hours.
8 . A process according to claim 1 , wherein said adding the solution occurs via a pump in the form of pulsed aliquots.
9 . A process according to claim 1 , wherein said adding the solution occurs over a period of between about 10 minutes and about 6 hours via a pump in the form of pulsed aliquots.
10 . A process according to claim 1 , wherein once the step of adding the solution to the non-solvent is completed, a slurry forms and the slurry is stirred over a period of between 0 and about 12 hours, followed by filtration of the slurry to recover fluticasone propionate as crystalline form 1 and drying of the recovered fluticasone propionate.
11 . A process according to claim 5 , wherein once the step of adding the solution to the non-solvent is completed, a slurry forms and the slurry is stirred over a period of between 0 and about 12 hours, followed by filtration of the slurry to recover fluticasone propionate as crystalline form 1 and drying of the recovered fluticasone propionate.
12 . A process according to claim 7 , wherein once the step of adding the solution to the non-solvent is completed, a slurry forms and the slurry is stirred over a period of between 0 and about 12 hours, followed by filtration of the slurry to recover fluticasone propionate as crystalline form 1 and drying of the recovered fluticasone propionate.
13 . A process according to claim 8 , wherein once the step of adding the solution to the non-solvent is completed, a slurry forms and the slurry is stirred over a period of between 0 and about 12 hours, followed by filtration of the slurry to recover fluticasone propionate as crystalline form 1 and drying of the recovered fluticasone propionate.
14 . Fluticasone propionate form 1, wherein said fluticasone propionate form 1 is obtained by a process according to according to claim 1 ,
wherein said fluticasone propionate form 1 has a median particle size of between 5 microns and 35 microns.
15 . Fluticasone propionate form 1, wherein said fluticasone propionate form 1 is obtained in the form of particles by a process according to according to claim 1 ,
wherein said particles do not exhibit agglomeration.
16 . Fluticasone propionate form 1, wherein said fluticasone propionate form 1 is obtained in the form of particles by a process according to according to claim 1 ,
wherein said particles are between 5 and 200 microns in length, and have a width of between 3 and 30 microns.Join the waitlist — get patent alerts
Track US2020024298A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.